Slingshot members are tracking this event:
Celgene Expected to Complete Four Phase 3 Trials of ABRAXANE in Different Indications in 2017
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Jan 19, 2018
Don’t see a project related to the catalyst you care about?
Related Keywords Abraxane, Phase 3 Clinical Trials, Pancreatic Cancer, Non-small Cell Lung Cancer